• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性间皮瘤2008年

Malignant mesothelioma 2008.

作者信息

Zervos Michael D, Bizekis Costas, Pass Harvey I

机构信息

Department of Cardiothoracic Surgery, Division of Thoracic Surgery, New York University School of Medicine, New York, USA.

出版信息

Curr Opin Pulm Med. 2008 Jul;14(4):303-9. doi: 10.1097/MCP.0b013e328302851d.

DOI:10.1097/MCP.0b013e328302851d
PMID:18520263
Abstract

PURPOSE OF REVIEW

Mesothelioma is an aggressive malignancy of the pleura with poor survival. There will be approximately 3000 cases of mesothelioma in the United States annually. Multimodality treatment including neoadjuvant chemotherapy in selected individuals followed by extrapleural pneumonectomy and radiation has been studied in recent trials for its effects on disease free and overall survival This review provides a general overview of malignant mesothelioma with a summary of the most significant articles from within the past year as well as from the past.

RECENT FINDINGS

Areas of recent interest include the evaluation of osteopontin and mesothelin as new tumor markers for mesothelioma. New phase III trials have been performed to evaluate the use of combined chemotherapy regimens.

SUMMARY

Malignant mesothelioma is a very difficult malignancy to treat. Patients with the disease usually have an occupational asbestos exposure, and in some, viral exposure with SV40. There have been many historical treatments including combinations of local control with surgery and radiation as well as attempts to prevent systemic failure with chemotherapy. Novel therapies including intrapleural chemotherapy, photodynamic therapy and hyperthermic perfusion have also been used with some success. Finally there are several attempts at immunomodulating and targeted treatments, which are in phase I/II trials.

摘要

综述目的

间皮瘤是一种侵袭性的胸膜恶性肿瘤,生存率低。美国每年约有3000例间皮瘤病例。近期试验研究了多模式治疗,包括对选定个体进行新辅助化疗,随后行胸膜外全肺切除术和放疗,观察其对无病生存期和总生存期的影响。本综述对恶性间皮瘤进行了概述,并总结了过去一年及以往最重要的文章。

最新发现

近期关注的领域包括评估骨桥蛋白和间皮素作为间皮瘤新的肿瘤标志物。已开展新的III期试验来评估联合化疗方案的应用。

总结

恶性间皮瘤是一种极难治疗的恶性肿瘤。该病患者通常有职业性石棉接触史,部分患者有SV40病毒接触史。过去有多种治疗方法,包括手术和放疗相结合的局部控制,以及尝试用化疗预防全身衰竭。新型疗法如胸膜内化疗、光动力疗法和热灌注疗法也取得了一定成功。最后,有几种免疫调节和靶向治疗正在进行I/II期试验。

相似文献

1
Malignant mesothelioma 2008.恶性间皮瘤2008年
Curr Opin Pulm Med. 2008 Jul;14(4):303-9. doi: 10.1097/MCP.0b013e328302851d.
2
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.恶性胸膜间皮瘤的诊断、评估及管理进展
Respirology. 2005 Jun;10(3):266-83. doi: 10.1111/j.1440-1843.2005.00714.x.
3
Future developments in the management of malignant pleural mesothelioma.恶性胸膜间皮瘤管理的未来发展
Expert Rev Anticancer Ther. 2009 Apr;9(4):453-67. doi: 10.1586/era.09.2.
4
[Recent progress in treatment of malignant pleural mesothelioma].[恶性胸膜间皮瘤治疗的最新进展]
Cancer Radiother. 2005 Nov;9(6-7):362-5. doi: 10.1016/j.canrad.2005.09.005. Epub 2005 Oct 10.
5
Multidisciplinary treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤的多学科治疗
Oncologist. 2007 Jul;12(7):850-63. doi: 10.1634/theoncologist.12-7-850.
6
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.一项关于II-III期恶性胸膜间皮瘤的胸膜内免疫化疗、胸膜切除术/纤维板剥脱术、放射治疗、全身化疗及长期皮下注射白细胞介素-2的II期研究。
Eur J Cardiothorac Surg. 2007 Mar;31(3):529-33; discussion 533-4. doi: 10.1016/j.ejcts.2006.11.046. Epub 2006 Dec 26.
7
[The clinical picture and therapy of malignant pleural mesothelioma].[恶性胸膜间皮瘤的临床表现与治疗]
Strahlenther Onkol. 1994 Nov;170(11):628-35.
8
[Environmental cancer: malignant pleural mesothelioma].[环境性癌症:恶性胸膜间皮瘤]
Bull Cancer. 2008 Jan;95(1):77-86. doi: 10.1684/bdc.2008.0566.
9
Management of malignant pleural mesothelioma.恶性胸膜间皮瘤的管理
Clin Chest Med. 2006 Jun;27(2):335-54. doi: 10.1016/j.ccm.2006.01.004.
10
[Treatment of malignant pleural mesothelioma--present status and future view].[恶性胸膜间皮瘤的治疗——现状与未来展望]
Fukuoka Igaku Zasshi. 2008 Apr;99(4):74-9.

引用本文的文献

1
Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese medical institution.基于 SEER 数据库和一家中国医疗机构建立并验证预测晚期恶性胸膜间皮瘤生存概率的列线图。
Front Endocrinol (Lausanne). 2023 Apr 14;14:1139222. doi: 10.3389/fendo.2023.1139222. eCollection 2023.
2
ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen.ALPPL2 是一种高度特异性和靶向性的肿瘤细胞表面抗原。
Cancer Res. 2020 Oct 15;80(20):4552-4564. doi: 10.1158/0008-5472.CAN-20-1418. Epub 2020 Aug 31.
3
Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review.
姜黄素在恶性间皮瘤中的抗癌作用:综述。
Int J Mol Sci. 2020 Mar 7;21(5):1839. doi: 10.3390/ijms21051839.
4
Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.姜黄素 C3 复合物®/黑胡椒素®对间皮瘤具有抗肿瘤活性:一项体外和体内分析。
J Exp Clin Cancer Res. 2019 Aug 16;38(1):360. doi: 10.1186/s13046-019-1368-8.
5
Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.腺病毒介导的内皮细胞蛋白 C 受体基因转染抑制小鼠恶性胸膜间皮瘤的进展。
Sci Rep. 2016 Nov 11;6:36829. doi: 10.1038/srep36829.
6
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.我们对间皮瘤发病机制的理解及靶向治疗设计的最新进展。
Expert Rev Respir Med. 2015 Oct;9(5):633-54. doi: 10.1586/17476348.2015.1081066. Epub 2015 Aug 26.
7
Lung cancer: Biology and treatment options.肺癌:生物学与治疗选择
Biochim Biophys Acta. 2015 Dec;1856(2):189-210. doi: 10.1016/j.bbcan.2015.08.002. Epub 2015 Aug 19.
8
Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.腺病毒介导的NK4基因疗法对间皮瘤癌干细胞样细胞的抑制作用。
Int J Cancer. 2015 Jul 15;137(2):481-90. doi: 10.1002/ijc.29391. Epub 2014 Dec 27.
9
Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5.西仑吉肽通过拮抗整合素αvβ3和αvβ5抑制恶性胸膜间皮瘤细胞的黏附和侵袭。
PLoS One. 2014 Mar 3;9(3):e90374. doi: 10.1371/journal.pone.0090374. eCollection 2014.
10
Malignant mesothelioma presenting as a gradually enlarging pneumothorax.表现为逐渐增大的气胸的恶性间皮瘤。
Case Rep Pulmonol. 2013;2013:374960. doi: 10.1155/2013/374960. Epub 2013 Oct 2.